Experts Will Convene This Week in Chicago to Discuss Impact of Immunotherapy and Biologics on Allergy Patient Care

World Allergy Organization Symposium Will Focus on Emerging Fields of Disease Treatment

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The Symposium will focus on current advances and future research needs in immunotherapy and biologics and their impact on understanding and treating increasingly complex allergic diseases and asthma in the individual patient.

Milwaukee, WI (PRWEB) December 10, 2013

Experts in the field of allergy and clinical immunology from around the world will convene in Chicago from December 13-14, 2013 for the WAO Symposium on Immunotherapy and Biologics, hosted by the World Allergy Organization (WAO). The Symposium will focus on current advances and future research needs in immunotherapy and biologics and their impact on understanding and treating increasingly complex allergic diseases and asthma in the individual patient.

“We have the privilege of bringing together 350 scientists and physicians to exchange knowledge about what is already known about immunotherapy and biologics and the innovations that are on the horizon, in order to further identify unmet needs and areas of research priority for the field of allergy and clinical immunology,” said Lanny Rosenwasser, MD, WAO President-Elect and Symposium Chair. Presentations by 40 international experts will cover new research findings in allergen immunotherapy and biological therapeutics and evaluate new directions in the diagnosis, treatment, and prevention of allergic diseases and asthma.

“The Symposium will highlight the most recent advances and recommendations on biologics and immunotherapy including sublingual immunotherapy and other novel forms of immunotherapy that will have a major impact on the current and future management of allergic diseases and asthma. As we better understand the complexity and phenotypes of these diseases, new diagnostic tools and more targeted therapies are required to meet the growing challenges of the severe and complex forms of these diseases,” said Ruby Pawankar, MD, PhD, WAO President and Symposium Chair.

Highlights of the program include (click on title for more information):

Personalized / Precision Medicine: Opportunities and Challenges (Keynote)
Personalized Medicine in Allergy and Asthma (Plenary)
Biologic Basis of the Allergic Response (Plenary)
Overview of Allergen Immunotherapy and Tolerance (Plenary)
New Treatments for Allergen Immunotherapy (Plenary)
Biologics Track
Immunotherapy Track

The full scientific program is available in PDF form and searchable online at http://www.worldallergy.org/program.

About the World Allergy Organization:

The World Allergy Organization (WAO) is an international alliance of 94 regional and national allergy, asthma and immunology societies. Through collaboration with its Member Societies WAO provides a wide range of educational and outreach programs, symposia and lectureships to allergists/immunologists around the world and conducts initiatives related to clinical practice, service provision, and physical training in order to better understand and address the challenges facing allergists/immunologists worldwide. For more information, visit worldallergy.org.

World Allergy Organization
555 E. Wells Street, Suite 1100
Milwaukee, Wisconsin 53202-3823 USA
Tel: +1 (414) 276-1791 Fax: +1 (414) 276-3349
Email: info(at)worldallergy(dot)org | Website: http://www.worldallergy.org


Contact

  • Katie Komassa
    Associate Director of Meetings, World Allergy Organization
    +1 (414) 276-1791
    Email
  • Samantha Machart
    Communications Manager, World Allergy Organization
    (414) 276-1791
    Email

Attachments